Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)
covax (2 trials)
covax-19 (2 trials)
covid-19 vaccine (vero cells) (3 trials)
dtap (5 trials)
hepatitis a vaccine, inactivated (vaqta) (1 trial)
inactivated covid-19 vaccine (4 trials)
inactivated influenza vaccine (1 trial)
ipv (3 trials)
live oral poliovirus type 1, 2 and 3 (2 trials)
measles, mumps and rubella vaccine (1 trial)
mmr (1 trial)
sipv (1 trial)
bivalent oral polio vaccine (bopv), type 1 and type 3 (2 trials)
haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (1 trial)
hepatitis b vaccine (recombinant) (recombivax) (1 trial)
inactivated SARS-Cov-2 vaccine (2 trials)
tdap-ipv vaccine (1 trial)
nvsi-06-08 (1 trial)
Hepatitis (Phase 3)
Hepatitis A (Phase 3)
Hepatitis B (Phase 3)
Measles (Phase 4)
Poliomyelitis (Phase 3)
Rubella (Phase 4)
Virus Diseases (Phase 3)
Trials (22 total)
Trial APIs (19 total)